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1. Introduction 
The structure and function of plasma lipoproteins 
have received increasing attention in the past few 
years. The recognition of the importance of the 
protein moiety for the structural stability and metab- 
olism of these conjugated macromolecules has 
stimulated this field of research and has emphasized 
the careful characterization of the apo-lipoproteins for a 
better understanding of lipid transport and metabolism. 
The classification and nomenclature in the lipo- 
protein field have been commonly based on two sets 
of operational terms. Differences in the hydrated 
density of plasma lipoproteins, which are largely a 
consequence of their lipid composition and differences 
in their electrophoretic mobility, which is primarily 
a consequence of their protein moiety, have provided 
the basis of a widely accepted classification system, 
comprising four major classes, each of which is 
characterized by a relatively narrow density range and 
a distinguished electrophoretic band. These are the 
very low density lipoproteins (VLDL; d < 1.006 
g/ml), which can be further subdivided into chylo- 
microns and pre$lipoproteins, the low density lipo- 
proteins (LDL; d 1.006- 1.063 g/ml) with P-mobility 
and the high density lipoproteins (HDL; d 1.063- 1.2 1 
glml) exhibiting a-mobility on electrophoresis. 
Since we know more about the protein moeity 
of the piasma lipoproteins, the so-called apo-lipo- 
proteins and their distribution between the different 
classes, so far three distinct are characterized (apo-A, 
apo-B and apo-C) each of which consists of subunits, 
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no one of the two classification systems based on 
density or electrophoretic mobility is any more ade- 
quate to describe the different classes of lipoproteins 
from a physiological-chemical point of view. This is 
particularly true for dyslipoproteinemias. It is also 
true for the LP(a)-lipoprotein first described by Berg 
[l] . It has been suggested by Berg [2] that the 
LP(a)-lipoprotein represents an inherited antigenic 
polymorphic system of the &lipoproteins which can 
be found in 30-35% of European population. In 
1968, Wiegand et al. [3] and Schultz et al. [4] were 
the first to describe the hydrated density of the 
LP(a)-lipoprotein within the density range of the 
high density lipoproteins (d 1.063- 1.2 1 g/ml). The 
isolated LP(a)-lipoprotein [5] reacted immunochemi- 
tally only with anti+-lipoprotein serum and anti-LP(a)- 
lipoprotein serum, but not with ant&-lipoprotein 
serum or anti-albumin serum. It contained less lipids 
than normal LDL. The aminoacid composition of 
apo-LP(a)-lipoprotein differs from that of apo-B and 
apo-A, the protein moieties of fl- and cr-lipoproteins 
[6]. Riedel et al. [7] and Simons et al. [6] demon- 
strated that the LP(a)-lipoprotein develops pre-/3- 
mobility on agarose electrophoresis. 
Since the preg-lipoprotein fraction normally 
consists predominantly of ape-lipoprotein C, the 
third ape-lipoprotein first described by Gustafson et 
al. [8] , it seemed justified and was the purpose of 
this study to analyze the LP(a)-lipoprotein in more 
detail with regard to its composition of apo-lipo-. 
proteins. 
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2. Material and methods 2.4. Delipidization 
2.1. Isolation of the LP(a)-lipoprotein 
Blood samples were obtained from healthy male 
and female volunteers, 24 to 45 years of age. The 
blood was usually drawn 10 hr after a meal, but 
never less than 5 hr after. It was collected for pre- 
parative isolation into flasks containing sodium citrate 
and the plasma was recovered by low speed centrifuga- 
tion. 
The plasma was adjusted to a solution density of 
d 1.063 g/ml by adding sodium bromide and layered 
under equal volumes of a sodium bromide solution 
with the density d 1.063 g/ml and centrifuged in the 
type Ti 50 Rotor of the Spinco Model L-2 ultracentri- 
fuge for 44 hr at 105,000 g and 4”. 
The isolated LP(a)-lipoprotein was delipidized 
according to a modification of the procedure of Scanu 
et al. [ 191. Five successive xtractions with ethanol- 
diethyl ether (3 : 1, v/v) followed by five extractions 
with diethyl ether at 0” were performed. After the 
final solvent treatment the essentially lipid-free pro- 
tein residues were removed by low speed centrifugation 
and were dried under nitrogen for several hours. 0.9% 
NaCl was added to redissolve the ape-lipoprotein C 
compound. 
3. Results and discussion 
‘Ihe top fraction was removed by a tube slicing 
technique and recentrifuged under the same conditions 
at the solution density of 1.12 g/ml. The top fraction 
after the second centrifuge run was dialyzed for 12 hr 
against 0.9% NaCl and further fractionated by column 
chromatography (2.1 X 30 cm) with hydroxylapatite 
according to the method of Tiselius et al. [9] , 
Hjertkn et al. [lo] and Cram& and Brattstein [ 1 l] in 
order to separate the LP(a)-lipoprotein from the 
a-lipoproteins. The LP(a)-lipoprotein was diluted with 
a K-phosphate buffer, pH 8.6,0.65 M. For details see 
Roelcke [ 121. 
Ultracentrifugation of the plasma from donors with 
immuno-chemically proven positive LP(a)-lipoprotein 
demonstrates that this plasma lipoprotein is within 
the density fraction d 1.063- 1.12 g/ml (HDL). The 
1.063 g/ml top fraction and the d 1.12 g/ml bottom 
fraction showed no immunoprecipitating reaction 
against the mono-specific anti-LP(a)-lipoprotein 
serum. The isolated LP(a)-lipoprotein develops preQ- 
Inobility on agarose electrophoresis (fig. 1). 
Whereas the density fraction d 1.063-l .12 g/ml 
reacted immuno-chemically with anti-&lipoprotein 
serum, the isolated LP(a)-lipoprotein showed no reac- 
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2.2. Immunological methods 
The immuno-chemical properties of the isolated 
LP(a)-lipoprotein were studied by double immuno- 
diffusion [ 131 and immunoelectrophoresis [ 141 in 
1% agarose gel employing a barbital buffer, pH 8.6, 
ionic strength 0.05. Rabbit anti-human sera to a-lipo- 
proteins, &lipoproteins and whole human serum 
(Behring Werke AC, MarburglLahn, Germany) were 
used. The rabbit anti-sera against lipoprotein-C and 
LP(a)-lipoprotein were prepared in our laboratories as 
described earlier [ 1, 151. As apo-C antigen either very 
low density lipoproteins or isolated LP(x) [15, 161 
was used. 
2.3. Elec trophoresis 
Lipid electrophoresis was performed according to 
the technique by Noble [ 171 with minor modifications 
[181. 
Fig. 1. Lipidelectrophoresis of whole plasma and the isolated 
LP(a)-lipoprotein fraction in 1% Agarosegel; Oil red 0 stained. 
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Fig. 2. Double immunodiffusion (1% Agargel) and immuno- 
electrophoresis (1% Agarosegel) of isolated LP(a)-lipoprotein. 
1 = anti-p-lipoprotein serum, 2 = anti-LP-(a)-lipoprotein 
serum, 3 = anti-LPC serum and 4 = anti-o-lipoprotein serum. 
tion against this anti-serum (fig. 2). However, the 
isolated LP(a)-lipoprotein reacted immune-chemically 
not only with anti-serum to normal &lipoproteins and 
with the specific anti-serum to the LP(a)-lipoprotein, 
but also with anti-serum to apo-lipoprotein C. By 
double immunodiffusion (see fig. 2) full identity was 
obtained between anti&lipoprotein serum, anti-LP(a)- 
lipoprotein serum and anti-ape-C serum, clearly in- 
dicating that the LP(a)-lipoprotein carries all three 
antigenic determinants. 
This finds support by the immuno-electrophoretic 
pattern of isolated LP(a)-lipoprotein, tested against 
anti-apoC- and anti-LP(a)-lipoprotein serum. The 
immunoprecipitating reaction against the two different 
anti-bodies develops in the same (preQ) position (see 
fig. 2). 
After total delipidization of the isolated LP(a)- 
lipoprotein only the apo-lipoprotein C compound was 
soluble in 0.9% NaCl and detectable by immuno-che- 
mical means. It seems therefore unlikely, that the 
specific antigenic determinant of the LP(a)-lipoprotein 
is located on or is a part of the ape-lipoprotein C 
protein moiety. Further studies are necessary to 
elucidate whether the specific antigenic determinant 
is part of the apo-B protein moiety or part of a 
separate protein moiety. These studies are in progress 
in our laboratories. 
Our data establish that the LP(a)-lipoprotein as 
other pre$lipoproteins consists of apo-lipoprotein C 
in addition to apo-lipoprotein B. However, with regard 
to the content of apo-lipoprotein A it seems to differ 
from the normal pre-fl-lipoproteins of the VLDL frac- 
tion, since this density class generally contains apo- 
lipoprotein A in small amounts. We were unable to 
detect apo-lipoprotein A by immunological means 
neither in the intact LP(a)-lipoprotein nor in its delip- 
idized form. Thus, the increase in mobility of the 
LP(a)-lipoprotein seems not to be due to the apo-lipo- 
protein A content, as discussed for the normal pre-/3- 
lipoproteins. It may, however, be a result of its sialic 
acid content as indicated by Simons 161. 
Although there is still much uncertainty about 
structural relations of the lipids to the proteins in the 
plasma lipoproteins, we feel that further emphasis on 
the characterization of the protein moieties of plasma 
lipoproteins, especially of those with abnormal 
physico-chemical characteristics, such as the LP(a)- 
lipoprotein, may provide a better understanding of 
lipid metabolism. 
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